Ovid Therapeutics Files Proxy Materials
Ticker: OVID · Form: DEFA14A · Filed: Apr 27, 2026 · CIK: 0001636651
| Field | Detail |
|---|---|
| Company | Ovid Therapeutics Inc. (OVID) |
| Form Type | DEFA14A |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-actions, shareholder-communication
TL;DR
Ovid Therapeutics filed proxy docs 4/27/26 - watch for shareholder votes.
AI Summary
Ovid Therapeutics Inc. filed a DEFA14A form on April 27, 2026, related to additional definitive proxy soliciting materials. The filing includes various documents such as iXBRL, graphics, and XBRL instance documents, detailing corporate actions and shareholder communications. The company is based in New York, NY.
Why It Matters
This filing indicates Ovid Therapeutics is engaging in shareholder communication and potentially seeking approval for corporate actions, which could impact the company's strategic direction and stock performance.
Risk Assessment
Risk Level: low — This filing is a standard proxy statement and does not inherently indicate significant new risks for the company.
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Filer
- 0001636651 (company) — CIK number for Ovid Therapeutics Inc.
- 2026-04-27 (date) — Filing Date
- 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 (location) — Mailing and Business Address
FAQ
What type of filing is this DEFA14A for Ovid Therapeutics Inc.?
This DEFA14A filing is for additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this DEFA14A filing accepted by the SEC?
The filing was accepted on 2026-04-27 at 17:12:01.
What is the CIK number for Ovid Therapeutics Inc.?
The CIK number for Ovid Therapeutics Inc. is 0001636651.
Where is Ovid Therapeutics Inc. located?
Ovid Therapeutics Inc.'s mailing and business address is 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001.
What SIC code is associated with Ovid Therapeutics Inc.?
The SIC code associated with Ovid Therapeutics Inc. is 2834, which falls under Pharmaceutical Preparations.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 27, 2026 regarding Ovid Therapeutics Inc. (OVID).